Wei Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Yao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Kai Li
Department of Pediatric Surgery, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China
3 shared publications Kuiran Dong
Children's Hospital of Fudan University
3 shared publicationsShan Zheng
Children's Hospital of Fudan University
3 shared publicationsKai Li
Children's Hospital of Fudan University
2 shared publicationsXianmin Xiao
Children's Hospital of Fudan University
2 shared publications- Zuopeng Wang
Children's Hospital of Fudan University
2 shared publications
Latest Publications
- Open Access
- 18 August 2025
- Published by Wiley
Prognosis of Pulmonary Metastasis in Pediatric Hepatoblastoma
Background Hepatoblastoma is the most common primary malignant liver tumor in children and 20% patients have pulmonary metastasis at diagnosis, which highly accepted abnormal AFP as the marker of diagnosis and recurrence, but no one pays attention to other serum markers. Methods Clinical data and serological markers were collected from pediatric HB patients who received systematic treatment at our hospital. Multivariate logistic regression was performed to identify independent risk factors for pulmonary metastasis in HB. Cox proportional hazards regression was further applied to analyze prognostic factors in the pulmonary metastasis group. Results A total of 146 HB patients were included in this study, comprising 117 non-metastasis cases and 29 pulmonary metastasis cases. Subgroup analysis of the 28 pulmonary metastasis cases showed that presence of extrapulmonary metastasis and pulmonary metastasis resection were significant prognostic factors. Cox regression analysis further indicated that Initial D-D/FIB >1.6, GPR >1.35, postoperative 1-month AFP >324.4 ng/ml, postoperative 2-month AFP >185.9 ng/ml, presence of extrapulmonary metastasis were prognostic risk factors. Conclusions The pulmonary metastasis group showed significantly lower OS and EFS compared to the non-metastasis group. Multifocal liver tumors, initial tumor diameter >10cm, and vascular tumor thrombus were identified as independent risk factors for pulmonary metastasis in HB. Additionally, presence of extrapulmonary metastasis, postoperative 1-month AFP and postoperative 2-month AFP were independent prognostic predictors for HB patients with pulmonary metastasis. Serological markers may serve as valuable indicators for monitoring disease progression and guiding prognosis in HB with pulmonary metastasis.
- 18 August 2025
- Published by Wiley
Open AccessPrognosis of Pulmonary Metastasis in Pediatric Hepatoblastoma
Background Hepatoblastoma is the most common primary malignant liver tumor in children and 20% patients have pulmonary metastasis at diagnosis, which highly accepted abnormal AFP as the marker of diagnosis and recurrence, but no one pays attention to other serum markers. Methods Clinical data and serological markers were collected from pediatric HB patients who received systematic treatment at our hospital. Multivariate logistic regression was performed to identify independent risk factors for pulmonary metastasis in HB. Cox proportional hazards regression was further applied to analyze prognostic factors in the pulmonary metastasis group. Results A total of 146 HB patients were included in this study, comprising 117 non-metastasis cases and 29 pulmonary metastasis cases. Subgroup analysis of the 28 pulmonary metastasis cases showed that presence of extrapulmonary metastasis and pulmonary metastasis resection were significant prognostic factors. Cox regression analysis further indicated that Initial D-D/FIB >1.6, GPR >1.35, postoperative 1-month AFP >324.4 ng/ml, postoperative 2-month AFP >185.9 ng/ml, presence of extrapulmonary metastasis were prognostic risk factors. Conclusions The pulmonary metastasis group showed significantly lower OS and EFS compared to the non-metastasis group. Multifocal liver tumors, initial tumor diameter >10cm, and vascular tumor thrombus were identified as independent risk factors for pulmonary metastasis in HB. Additionally, presence of extrapulmonary metastasis, postoperative 1-month AFP and postoperative 2-month AFP were independent prognostic predictors for HB patients with pulmonary metastasis. Serological markers may serve as valuable indicators for monitoring disease progression and guiding prognosis in HB with pulmonary metastasis.
- 26 March 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (7) , 1203-1210
Overexpression Prox1 in HemECs resembles Kaposiform hemangioendothelioma and cytotoxicity of sirolimus in vitro
- 26 March 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (7) , 1203-1210
Overexpression Prox1 in HemECs resembles Kaposiform hemangioendothelioma and cytotoxicity of sirolimus in vitro
- Open Access
- 20 October 2020
- Published by Wiley
Comparison of efficacy and safety of corticosteroid and vincristine in treating Kaposiform hemangioendothelioma and tufted angioma: A Multiicenter Prospective Randomized Controlled Clinical Trial
Purpose: To evaluate and compare the efficacy of corticosteroid and vincristine (VCR) in the treatment of kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). Methods: This was a multicenter prospective randomized controlled study. All patients with KHE/TA who meet the diagnostic criteria were included. The patients were randomized to methylprednisolone (MP) group and VCR group. The primary outcome was the single main parameter effective rate (SMPE) and overall effective rate (OE) of corticosteroid and VCR over one month after treatment. The single main parameters included platelets, fibrinogen, tumor size, texture and appearance. Results: In single main parameters, VCR was superior to corticosteroid in the relief of platelet (80.0% vs 44.0, P = 0.019) and tumor texture (68.9% vs 30.8%, P = 0.007). Although the efficacy of VCR on fibrinogen (23.3% vs 20.7%, P=1.000), tumor size (23.3% vs 13.8%, P=0.273) and appearance (65.5% vs 46.2%, P=0.120) were higher than that of corticosteroid, there was no significant difference (P > 0.05). And the overall effective rate of VCR was higher than that of corticosteroid (31.0% and 56.7% vs 31.0%), but the differences were also not statistically significant. (P=0.067). Conclusions: Our prospective data show that the therapeutic effect of VCR was significantly greater than that of corticosteroid with regard to treating thrombocytopenia and improving tumor texture. So, we recommend that VCR could be an option for first-line treatment in KHE/TA patients.
- 20 October 2020
- Published by Wiley
Open AccessComparison of efficacy and safety of corticosteroid and vincristine in treating Kaposiform hemangioendothelioma and tufted angioma: A Multiicenter Prospective Randomized Controlled Clinical Trial
Purpose: To evaluate and compare the efficacy of corticosteroid and vincristine (VCR) in the treatment of kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). Methods: This was a multicenter prospective randomized controlled study. All patients with KHE/TA who meet the diagnostic criteria were included. The patients were randomized to methylprednisolone (MP) group and VCR group. The primary outcome was the single main parameter effective rate (SMPE) and overall effective rate (OE) of corticosteroid and VCR over one month after treatment. The single main parameters included platelets, fibrinogen, tumor size, texture and appearance. Results: In single main parameters, VCR was superior to corticosteroid in the relief of platelet (80.0% vs 44.0, P = 0.019) and tumor texture (68.9% vs 30.8%, P = 0.007). Although the efficacy of VCR on fibrinogen (23.3% vs 20.7%, P=1.000), tumor size (23.3% vs 13.8%, P=0.273) and appearance (65.5% vs 46.2%, P=0.120) were higher than that of corticosteroid, there was no significant difference (P > 0.05). And the overall effective rate of VCR was higher than that of corticosteroid (31.0% and 56.7% vs 31.0%), but the differences were also not statistically significant. (P=0.067). Conclusions: Our prospective data show that the therapeutic effect of VCR was significantly greater than that of corticosteroid with regard to treating thrombocytopenia and improving tumor texture. So, we recommend that VCR could be an option for first-line treatment in KHE/TA patients.
- Open Access
- 14 October 2020
- Published by Wiley
Outcomes of Extended Hepatic Resection for POST-TEXT III and IV Hepatoblastoma: a single center experience
Objective: To investigate the long-term outcomes of extended hepatectomy for POST-TEXT III and IV hepatoblastoma. Methods: The clinical data of 35 patients with POST-TEXT III and IV hepatoblastoma from January 2009 to June 2019 were analyzed retrospectively. Results: There were 34 cases of POST-TEXT III and 1 cases of POST-TEXT IV, respectively. All 35 cases underwent hepatic resection, including 7 cases of hepatic trisectionectomy, 8 cases of extended hemihepatectomy, 4 cases of irregular hepatectomy, 12 cases of mesohepatectomy and 4 cases of ALPPS procedure. Pringle maneuver and Glissonean approach was used in 4 and 22 patients, respectively. The average blood loss of patients with Glissonean approach (147.73 ± 137.46ml) was significantly less than that of patients without the approach (387.69 ± 235.69ml; P = 0.001). The 5-year overall survival rate and event-free survival rate was 79.2% and 73.7%, respectively. According to the classification of tumor margin distance, the 5-year overall survival rates of the tumors with margin > 1cm, 0.5-1cm, < 0.5cm and close to the tumor margin were 100%, 78.0%, 83.3% and 53.3%, respectively (P=0.371). Seven patients developed recurrence which occurred within 1 year after tumor resection. Conclusion: Non-transplant extended hepatic resection is a feasible approach for POST-TEXT III and IV hepatoblastomas. On the basis of mastering the Glisson approach and ensuring a certain resection margin, it is possible to achieve a similar oncological outcome to liver transplantation.
- 14 October 2020
- Published by Wiley
Open AccessOutcomes of Extended Hepatic Resection for POST-TEXT III and IV Hepatoblastoma: a single center experience
Objective: To investigate the long-term outcomes of extended hepatectomy for POST-TEXT III and IV hepatoblastoma. Methods: The clinical data of 35 patients with POST-TEXT III and IV hepatoblastoma from January 2009 to June 2019 were analyzed retrospectively. Results: There were 34 cases of POST-TEXT III and 1 cases of POST-TEXT IV, respectively. All 35 cases underwent hepatic resection, including 7 cases of hepatic trisectionectomy, 8 cases of extended hemihepatectomy, 4 cases of irregular hepatectomy, 12 cases of mesohepatectomy and 4 cases of ALPPS procedure. Pringle maneuver and Glissonean approach was used in 4 and 22 patients, respectively. The average blood loss of patients with Glissonean approach (147.73 ± 137.46ml) was significantly less than that of patients without the approach (387.69 ± 235.69ml; P = 0.001). The 5-year overall survival rate and event-free survival rate was 79.2% and 73.7%, respectively. According to the classification of tumor margin distance, the 5-year overall survival rates of the tumors with margin > 1cm, 0.5-1cm, < 0.5cm and close to the tumor margin were 100%, 78.0%, 83.3% and 53.3%, respectively (P=0.371). Seven patients developed recurrence which occurred within 1 year after tumor resection. Conclusion: Non-transplant extended hepatic resection is a feasible approach for POST-TEXT III and IV hepatoblastomas. On the basis of mastering the Glisson approach and ensuring a certain resection margin, it is possible to achieve a similar oncological outcome to liver transplantation.
- 1 July 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , 677-680
Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus
We present a retrospective case series of 3 patients with retroperitoneal kaposiform hemangioendothelioma (KHE) complicated by Kasabach-Merritt phenomenon (KMP) and biliary obstruction. We found sirolimus to be a safe and effective treatment for these patients who were refractory to other treatment modalities. However, our patients were slow to respond in comparison to published reports of sirolimus use for KHE without biliary obstruction. We postulate that therapeutic serum levels of sirolimus may be affected by biliary obstruction and improved with surgical alleviation of the obstruction.
- 1 July 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , 677-680
Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus
We present a retrospective case series of 3 patients with retroperitoneal kaposiform hemangioendothelioma (KHE) complicated by Kasabach-Merritt phenomenon (KMP) and biliary obstruction. We found sirolimus to be a safe and effective treatment for these patients who were refractory to other treatment modalities. However, our patients were slow to respond in comparison to published reports of sirolimus use for KHE without biliary obstruction. We postulate that therapeutic serum levels of sirolimus may be affected by biliary obstruction and improved with surgical alleviation of the obstruction.
- 7 June 2018
- Published by Springer Nature in Pediatric Surgery International
- Vol. 34 (8) , 851-856
Comparison of long-term prognosis of laparoscopic and open adrenalectomy for local adrenal neuroblastoma in children
To investigate and compare long-term outcomes in children undergoing laparoscopic or open adrenalectomy for local adrenal neuroblastoma.
- 7 June 2018
- Published by Springer Nature in Pediatric Surgery International
- Vol. 34 (8) , 851-856
Comparison of long-term prognosis of laparoscopic and open adrenalectomy for local adrenal neuroblastoma in children
To investigate and compare long-term outcomes in children undergoing laparoscopic or open adrenalectomy for local adrenal neuroblastoma.